Certara, Inc. CERT 深 滬
等待開盤 12-20 09:30:00 美东时间
9.095
+0.215
+2.42%
華盛通- 最 高9.15
- 今 開8.93
- 成交量 76.70万股
- 最 低 8.93
- 昨 收 8.88
- 總市值 14.73亿
- 52周最高 15.69
- 市盈率 靜 --
- 換手率 0.47%
- 52周最低 8.025
- 委 比 -46.81%
- 總股本 1.62亿
- 歷史最高 45.48
- 量 比 0.38
- 振 幅 2.48%
- 歷史最低 8.025
- 每 手 1
- 風險率 1.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
12-19 10:15
Morgan Stanley Maintains Equal-Weight on Certara, Lowers Price Target to $12
Morgan Stanley analyst Sean Laaman maintains Certara (NASDAQ:CERT) with a Equal-Weight and lowers the price target from $16 to $12.
12-19 01:42
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
12-16 09:36
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
12-15 15:30
Certara Names Jon Resnick as CEO, William Feehery to Transition to Advisor, Reaffirms 2025 Outlook
Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, announced today that it has appointed Jon Resnick as its next Chief Executive Officer and member of Certara's Board of Directors, effective
12-11 19:02
Zapata Quantum Adds Financial Veteran William Klitgaard to Board as Company Aims to Relist on National Exchange
Zapata Quantum appoints William Klitgaard to the Board of Directors and Chair of the Audit Committee, and Clark Golestani as Chairman of the Board, to accelerate SEC compliance and exchange uplisting plans. These appointments follow the completion of the first two phases of the Company’s strategic restructuring efforts, which strengthened its balance sheet and recapitalized the business, raising over $4 million in new capital and restructuring $1...
11-20 13:00
Preview: Veeva Sys's Earnings
Veeva Sys (NYSE:VEEV) is gearing up to announce its quarterly earnings on Thurs...
11-19 22:02
Best AI productivity beneficiary stocks - Goldman
Goldman Sachs has identified a new group of “AI productivity beneficiaries,” highlighting companies best positioned to see earnings lift from automation-driven efficiency gains. Strategist David Kosti...
11-18 21:52
The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia
Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive productivity-led growth.
11-17 23:47
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
